Core Points - dsm-firmenich has successfully completed the sale of its stake in the Feed Enzymes Alliance to Novonesis for €1.5 billion [1] - The net cash received by dsm-firmenich after transaction costs is approximately €1.4 billion [2] Company Overview - dsm-firmenich is a Swiss company listed on Euronext Amsterdam, specializing in nutrition, health, and beauty, with revenues exceeding €12 billion [3] - The company operates in nearly 60 countries and employs around 30,000 people, focusing on creating sustainable solutions with natural and renewable ingredients [3]